Ownership history in WOLVERINE TRADING, LLC · 18 quarters on record
This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in ALDEYRA THERAPEUTICS INC (ALDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | REDUCED | 10,600 | -1,428 | -11.9% | 0.00% | $40K | $3.83 |
| 2025 Q1 | REDUCED | 12,028 | -16,972 | -58.5% | 0.00% | $80K | $5.75 |
| 2025 Q1 | ADDED | 29,000 | +11,100 | +62.0% | 0.00% | $193K | $5.75 |
| 2024 Q4 | REDUCED | 17,900 | -8,200 | -31.4% | 0.00% | $90K | $4.99 |
| 2024 Q3 | ADDED | 26,100 | +15,000 | +135.1% | 0.00% | $144K | $5.39 |
| 2024 Q1 | REDUCED | 11,100 | -9,166 | -45.2% | 0.00% | $36K | $3.27 |
| 2023 Q3 | ADDED | 20,266 | +2,908 | +16.8% | 0.00% | $135K | $6.68 |
| 2023 Q2 | REDUCED | 17,358 | -19,542 | -53.0% | 0.00% | $137K | $8.39 |
| 2023 Q2 | ADDED | 36,900 | +14,893 | +67.7% | 0.00% | $292K | $8.39 |
| 2023 Q1 | REDUCED | 22,007 | -5,693 | -20.6% | 0.00% | $209K | $9.93 |
As of 2025 Q4 — sorted by position size